Both in Pharmaceuticals
Xeris Biopharma Holdings vs Generate Biomedicines
Over the past year XERS returned +42.6% and GENB returned −11.5%; their daily moves had a correlation of 0.37.
XERS +42.6% GENB −11.5%Growth of $1, one year, split-adjusted
| Metric | XERS | GENB |
|---|---|---|
| Price | $10.63 | $13.92 |
| Market cap | $1.94B | $1.79B |
| Today | +2.66% | +0.51% |
| 1 month | +5.5% | +0.9% |
| 6 months | +66.8% | — |
| Year to date | +35.4% | — |
| 1 year | +7.3% | — |
| Revenue growth (YoY) | +28.7% | — |
| Gross margin | 86.4% | 100.0% |
| Net margin | −33.8% | −1065.2% |
| P/E (TTM) | — | — |
| Price / sales | 5.8× | — |
| Net cash | -$130.8M | $452.3M |
| Dividend yield | — | — |
| Volatility (60d) | 51.8% | — |
| Short % of float | 4.6% | 15.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).